Weil, Gotshal & Manges LLP represented AltC Acquisition Corp., while Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP represented Oklo Inc. in the transaction. An advanced...
AltC Acquisition Corp.’s Business Combination with Oklo
Alimera Sciences’ Acquisition of U.S. Commercial Rights to YUTIQ®
Gunderson Dettmer represented Alimera Sciences on the transaction, while Sidley Austin LLP represented EyePoint Pharmaceuticals, Inc. Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a global pharmaceutical company, has...
Raymond James Financial’s Acquisition of SumRidge Partners
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised SumRidge Partners on the deal. SumRidge Partners, a financial services company, announced its acquisition by Raymond James Financial,...
GSK’s $3.3 Billion Acquisition of Affinivax
Davis Polk advised GSK plc on the deal while Gunderson Dettmer represented Affinivax. GSK plc announced its acquisition of Affinivax, Inc. for a $2.1 billion upfront...
Meta’s Acquisition of Kustomer
Hengeler Mueller advised Meta on the merger investigation of the German Federal Cartel Office while Gunderson Dettmer represented Kustomer. The German Federal Cartel Office approved Meta...
Synchronoss’ Two Public Offerings and Private Placement
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Synchronoss on the deal. Synchronoss Technologies, Inc. (NASDAQ: SNCR), a global leader and innovator of cloud, messaging and...
Flywire’s IPO
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian LLP advised Flywire on the deal. Boston-based global payments enablement and software company, Flywire, announced its initial public offering. The company...